Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Sep 28, 2010

Premium

Pacific Biosciences has appointed David Baltimore to its board of directors, the company disclosed in a filing with the Securities and Exchange Commission this month.

Since 2006, Baltimore has been the president emeritus and the Robert Andrews Millikan Professor of Biology at the California Institute of Technology, and was the president of Caltech from 1997 to 2006. Before that, he was a professor at the Massachusetts Institute of Technology and Rockefeller University, where he also served as president. He was co-recipient of the Nobel Prize in medicine in 1975, and received the National Medal of Science in 1999.

Baltimore holds a BA in chemistry from Swarthmore College, a PhD from Rockefeller University, and was a postdoctoral fellow at MIT and the Albert Einstein College of Medicine.



Helicos BioSciences
has appointed Ivan Trifunovich as executive chairman of its board of directors, replacing Stanley Lapidus, who stepped down from the position of executive chairman but will continue to serve on the board.

Trifunovich has been providing consulting services to Helicos since August, earning $45,000. As executive chairman he will earn $30,000 per month. From 2001 to 2008, Trifunovich served as senior vice president for molecular diagnostics firm Third Wave Technologies. He has also held management positions at Pharmacia and Johnson & Johnson.

He holds a PhD in organic chemistry from the University of California, Los Angeles, and an MBA from the University of Pennsylvania's Wharton School of Business.


Metamark Genetics has named Gregory Critchfield to its board of directors. Critchfield served as president and board member of Myriad Genetic Laboratories until March, when he retired. At Myriad, he was responsible for building the company's scientific, medical, and commercial capabilities and launching seven molecular diagnostic products across a variety of technology platforms. He was also recently named to the board of Saladax Biomedical, a diagnostic test developer.



Carlos Bustamante
has been named a 2010 MacArthur Fellow. Bustamante is a professor of genetics and population biologist at Stanford University School of Medicine. He uses sequence data to study human migration, evolution, and natural selection. He holds his BA and PhD from Harvard University, and was a postdoctoral fellow at the University of Oxford.
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.